MeSH Browser

MeSH Heading: Burkitt Lymphoma
Tree Number(s): C01.925.256.466.313.165; C01.925.928.313.165; C04.557.386.480.150.165; C15.604.515.569.480.150.165; C20.683.515.761.480.150.165
Unique ID: D002051
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D002051
Scope Note: A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.
Entry Term(s): African Lymphoma; Burkitt Cell Leukemia; Burkitt Leukemia; Burkitt Tumor; Burkitt's Leukemia; Burkitt's Lymphoma; Burkitt's Tumor; Leukemia, Lymphoblastic, Burkitt-Type; Leukemia, Lymphocytic, L3; Lymphocytic Leukemia, L3; Lymphoma, Burkitt
Public MeSH Note: 1998; see BURKITT'S LYMPHOMA 1968-1997; for LEUKEMIA, B-CELL, ACUTE & BURKITT LEUKEMIA see LEUKEMIA, B-CELL, ACUTE 1989-2007; for BURKITT TUMOR see BURKITT'S TUMOR 1968-1997; for LYMPHOMA, BURKITT see LYMPHOMA, BURKITT'S 1968-1997
History Note: 1998 (1968)
Date Established: 1968/01/01
Date of Entry: 1999/01/01
Revision Date: 2020/02/28

Allowable Qualifiers: blood (BL)

cerebrospinal fluid (CF)

chemically induced (CI)

chemistry (CH)

classification (CL)

complications (CO)

congenital (CN)

diagnosis (DI)

diagnostic imaging (DG)

diet therapy (DH)

drug therapy (DT)

economics (EC)

embryology (EM)

enzymology (EN)

epidemiology (EP)

ethnology (EH)

etiology (ET)

genetics (GE)

history (HI)

immunology (IM)

metabolism (ME)

microbiology (MI)

mortality (MO)

nursing (NU)

parasitology (PS)

pathology (PA)

physiopathology (PP)

prevention & control (PC)

psychology (PX)

radiotherapy (RT)

rehabilitation (RH)

surgery (SU)

therapy (TH)

ultrastructure (UL)

urine (UR)

veterinary (VE)

virology (VI)

Concept UI: M0003058
Scope Note: A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.
Terms: Burkitt Lymphoma Preferred Term
Term UI T005821
Date01/01/1999
LexicalTag EPO
ThesaurusID; Burkitt Tumor
Term UI T005823
Date03/29/1974
LexicalTag EPO
ThesaurusID UNK (19XX); Burkitt's Tumor
Term UI T005822
Date10/03/1996
LexicalTag EPO
ThesaurusID NLM (1998); Burkitt's Lymphoma
Term UI T005819
Date10/03/1996
LexicalTag EPO
ThesaurusID; Lymphoma, Burkitt
Term UI T005820
Date03/29/1974
LexicalTag EPO
ThesaurusID UNK (19XX)

Concept UI: M000646519
Terms: Burkitt Leukemia Preferred Term
Term UI T045625
Date06/09/1988
LexicalTag EPO
ThesaurusID UNK (19XX); Burkitt Cell Leukemia
Term UI T684269
Date10/20/2006
LexicalTag EPO
ThesaurusID NLM (2008); Leukemia, Lymphocytic, L3
Term UI T045633
Date06/09/1988
LexicalTag NON
ThesaurusID UNK (19XX); Lymphocytic Leukemia, L3
Term UI T045634
Date06/09/1988
LexicalTag NON
ThesaurusID UNK (19XX); Burkitt's Leukemia
Term UI T045624
Date09/30/1996
LexicalTag EPO
ThesaurusID NLM (1998); Leukemia, Lymphoblastic, Burkitt-Type
Term UI T045628
Date06/09/1988
LexicalTag EPO
ThesaurusID UNK (19XX)

Burkitt Lymphoma MeSH Descriptor Data 2024